249: A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency

Journal article

Peer reviewed

A. Zuckermann, A. Keogh, M.G. Crespo-Leiro, D. Mancini, F. Gonzalez-Vilchez, L. Almenar, S. Brozena, H. Eisen, S. See Tai and S. Kashwaha

The Journal of heart and lung transplantation, v 29(2), pp S85-S85

Feb 2010

Additional Links

8 Record Views

Title: 249: A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency
Creators: A. Zuckermann - Arbeitsgemeinschaft für Klinische Ernährung
A. Keogh - St Vincent's Hospital Sydney
M.G. Crespo-Leiro - Complexo Hospitalario Universitario A Coruña
D. Mancini - Columbia University Irving Medical Center
F. Gonzalez-Vilchez - Marqués de Valdecilla University Hospital
L. Almenar - Hospital La Fe, Valencia, Spain
S. Brozena - University of Pennsylvania
H. Eisen - Drexel University
S. See Tai - Wyeth Pharmaceuticals, Collegeville, PA
S. Kashwaha - MAYO CLINIC ROCHESTER, Rochester, MN
Publication Details: The Journal of heart and lung transplantation, v 29(2), pp S85-S85
Publisher: Elsevier
Resource Type: Journal article
Language: English
Web of Science ID: WOS:000274756100248
Other Identifier: 991019335515204721

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Web of Science research areas: Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation